These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21255742)

  • 1. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2.
    Seshadri S; Beiser A; Au R; Wolf PA; Evans DA; Wilson RS; Petersen RC; Knopman DS; Rocca WA; Kawas CH; Corrada MM; Plassman BL; Langa KM; Chui HC
    Alzheimers Dement; 2011 Jan; 7(1):35-52. PubMed ID: 21255742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.
    Mayeux R; Reitz C; Brickman AM; Haan MN; Manly JJ; Glymour MM; Weiss CC; Yaffe K; Middleton L; Hendrie HC; Warren LH; Hayden KM; Welsh-Bohmer KA; Breitner JC; Morris JC
    Alzheimers Dement; 2011 Jan; 7(1):15-34. PubMed ID: 21255741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of older persons without cognitive impairment from two community-based studies.
    Bennett DA; Schneider JA; Arvanitakis Z; Kelly JF; Aggarwal NT; Shah RC; Wilson RS
    Neurology; 2006 Jun; 66(12):1837-44. PubMed ID: 16801647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States.
    Wilson RS; Weir DR; Leurgans SE; Evans DA; Hebert LE; Langa KM; Plassman BL; Small BJ; Bennett DA
    Alzheimers Dement; 2011 Jan; 7(1):74-9. PubMed ID: 21255745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1.
    Weir DR; Wallace RB; Langa KM; Plassman BL; Wilson RS; Bennett DA; Duara R; Loewenstein D; Ganguli M; Sano M
    Alzheimers Dement; 2011 Jan; 7(1):94-109. PubMed ID: 21255747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2.
    Evans DA; Grodstein F; Loewenstein D; Kaye J; Weintraub S
    Alzheimers Dement; 2011 Jan; 7(1):110-23. PubMed ID: 21255748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mild cognitive impairment: a population-based study in elderly subjects.
    Hänninen T; Hallikainen M; Tuomainen S; Vanhanen M; Soininen H
    Acta Neurol Scand; 2002 Sep; 106(3):148-54. PubMed ID: 12174174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States.
    Rocca WA; Petersen RC; Knopman DS; Hebert LE; Evans DA; Hall KS; Gao S; Unverzagt FW; Langa KM; Larson EB; White LR
    Alzheimers Dement; 2011 Jan; 7(1):80-93. PubMed ID: 21255746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor/psychomotor dysfunction in normal aging, mild cognitive decline, and early Alzheimer's disease: diagnostic and differential diagnostic features.
    Kluger A; Gianutsos JG; Golomb J; Ferris SH; Reisberg B
    Int Psychogeriatr; 1997; 9 Suppl 1():307-16; discussion 317-21. PubMed ID: 9447451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
    de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
    J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment: transition between aging and Alzheimer's disease.
    Petersen RC
    Neurologia; 2000 Mar; 15(3):93-101. PubMed ID: 10846869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Sperling RA; Aisen PS; Beckett LA; Bennett DA; Craft S; Fagan AM; Iwatsubo T; Jack CR; Kaye J; Montine TJ; Park DC; Reiman EM; Rowe CC; Siemers E; Stern Y; Yaffe K; Carrillo MC; Thies B; Morrison-Bogorad M; Wagster MV; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):280-92. PubMed ID: 21514248
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.